The number of railway lines both operational and under construction is growing rapidly, leading to an increase in the number of buildings adversely affected by ground-borne vibration (e.g. shaking and indoor noise). Post-construction mitigation measures are expensive, thus driving the need for early stage prediction, during project planning/development phases. To achieve this, scoping models (i.e. desktop studies) are used to assess long stretches of track quickly, in absence of detailed design information. This paper presents a new, highly customisable scoping model, which can analyse the effect of detailed changes to train, track and soil on ground vibration levels. The methodology considers soil stiffness and the combination of both the dynamic and static forces generated due to train passage. It has low computational cost and can predict free-field vibration levels in accordance with the most common international standards. The model uses the direct stiffness method to compute the soil Green's function, and a novel two-and-a-half dimensional (2.5D) finite element strategy for train-track interaction. The soil Green's function is modulated using a neural network (NN) procedure to remove the need for the time consuming computation of track-soil coupling. This modulation factor combined with the new train-track approach results in a large reduction in computational time. The proposed model is validated by comparing track receptance, free-field mobility and soil vibration with both field experiments and a more comprehensive 2.5D combined finite element-boundary element (FEM-BEM) model. A sensitivity analysis is undertaken and it is shown that track type, soil properties and train speed have a dominant effect on ground vibration levels. Finally, the possibility of using average shear wave velocity introduced for seismic site response analysis to predict vibration levels is investigated and shown to be reasonable for certain smooth stratigraphy's.
Background The proportion of Merkel cell carcinomas (MCCs) in solid-organ transplant recipients (SOTR) harbouring Merkel cell polyomavirus (MCPyV) is unknown, as are factors affecting their outcomes.Objective To describe clinicopathological features of MCC in SOTR, investigate the tumoral MCPyV-status and identify factors associated with tumour outcomes. Methods Retrospective, international, cohort-study. MCPyV-status was investigated by immunohistochemistry and polymerase chain reaction.Results A total of 30 SOTR and 44 consecutive immunocompetent patients with MCC were enrolled. SOTR were younger at diagnosis (69 vs. 78 years, P < 0.001). Thirty-three percent of SOTR MCCs were MCPyV-positive vs. 91% of immunocompetent MCCs (P = 0.001). Solid-organ transplantation was associated with an increased cumulative incidence of progression ], P = 0.002), MCC-specific mortality (SHR: 2.55 [1.07-6.06], P = 0.034) and overall mortality .9], P = 0.002). MCPyV-positivity and switching to an mTOR inhibitor (mTORi) after MCC diagnosis were associated with an increased incidence of progression , P = 0.008 and SHR: 3.6 [1.1-12], P = 0.032 respectively) in SOTR.Limitations Retrospective design and heterogeneity of SOTR cohort.
Can war be abolished? Is it a custom or is it intrinsic to human nature? These questions are of great importance today, because there is no task more important on the historical agenda of our times than the abolition of this age-old custom that has become so destructive that it threatens the very life of the planet. As Sigmund Freud wrote to Albert Einstein in their famous correspondence of 1932 on this subject, "These two factors-man's cultural disposition and well-founded fear of the form that future wars will take-may serve to put an end to war ... but by what ways or byways this will come about, we cannot guess."
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.